Pictured: Laurie Glimcher, Craig Thompson, Marc Tessier-Lavigne & Tadataka Yamada
Announcement
By Jim Stallard, MA, Writer/Editor  |  Thursday, October 24, 2013

Memorial Sloan Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.

Mouse glioblastoma tumor with phagocytic macrophages
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, October 15, 2013

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.

Breast cancer mosaic
Snapshot
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, October 9, 2013

Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.

Pictured: Pseudomonas aeruginosa
Snapshot
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, October 1, 2013

Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.

Pictured: Daniel Thorek & Jan Grimm
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, September 25, 2013

A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.

Pictured: Derek Tan
Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Monday, September 16, 2013

In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs.

Pictured: Lawrence Dauer
In the O.R.
By Media Staff  |  Tuesday, September 10, 2013

Memorial Sloan Kettering clinicians report on a successful first year of using a new procedure to pinpoint and remove small breast cancers.

Pictured: Kenneth Offit
In the Lab
By Maureen Salamon, BA, Freelance Writer  |  Monday, September 9, 2013

Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.

Pictured: Cancer cell lines
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, August 26, 2013

A recent study found that the cell lines most commonly used for research on ovarian cancer are not the most suitable.

Pictured: Robert J. Motzer
In the Clinic
By Maureen Salamon, BA, Freelance Writer  |  Thursday, August 22, 2013

An international study led by Memorial Sloan Kettering found that pazopanib (Votrient®) controls cancer as effectively as sunitinib (Sutent®) while improving patients’ quality of life.

Pictured: Micropapillary Morphology
In the Lab
By Esther Napolitano, BS, Science Writer/Editor  |  Friday, August 9, 2013

A Memorial Sloan Kettering study shows that an abnormal cell pattern found in the tumor tissue of some lung cancer patients may help to predict which tumors are more likely to recur after surgery.

Pictured: Clostridium difficile
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, August 7, 2013

Information about the microbiome, the genes of all the microorganisms that naturally inhabit the human body, is leading to new approaches for treating infections in cancer patients.

In the Clinic
By Memorial Sloan Kettering  |  Wednesday, June 19, 2013

A Memorial Sloan Kettering study suggests that lymphedema of the arm, a swelling that can occur following breast cancer treatment, may be reduced by acupuncture.

Pictured: Jedd Wolchok & Richard Carvajal
In the Clinic
By Media Staff  |  Monday, June 3, 2013

Two Memorial Sloan Kettering studies that hold promise for the treatment of advanced uveal (eye) melanoma and advanced skin melanoma are making headlines at the 49th Annual Meeting of the American Society of Clinical Oncology.

Pictured: Three-dimensional structure of the protein mTOR
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, May 30, 2013

In an eagerly awaited study, Memorial Sloan Kettering researchers report on the molecular structure of mTOR, a protein commonly mutated in cancer.

Center News

Stay Informed

Get the latest information about cancer care and research every month.